Diseases, Conditions, Syndromes

Highly potent, stable nanobodies stop SARS-CoV-2

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants. These so-called nanobodies bind and neutralize the virus up to 1,000 times better than ...

Diseases, Conditions, Syndromes

To stop a pandemic in its tracks, coordinate across borders

On March 16, 2020, the governors of New York, New Jersey, and Connecticut announced "a regional approach to combatting COVID-19," citing an absence of federal leadership and national standards. Pennsylvania joined two days ...

Diseases, Conditions, Syndromes

New treatment pathways for hepatitis C

A newly published Burnet Institute study has demonstrated the feasibility and effectiveness of simplified clinical pathways for treatment of hepatitis C (HCV) in Myanmar.

Diseases, Conditions, Syndromes

Pfizer says third shot of vaccine boosts COVID protection

New data show that protection from both doses of the Pfizer COVID-19 vaccine decreases slightly over time, but that a third dose significantly boosts levels of antibodies against several variants of the virus, including the ...

page 1 from 5